News Fresenius SE & Co. KGaA

Equities

FRE

DE0005785604

Market Closed - Xetra Other stock markets 11:41:49 2024-04-15 am EDT			Pre-market 01:32:00 am
25.45 ^EUR	+0.12%		25.34	-0.43%

05:13pm	European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	MT
Mar. 22	Cannabis law and clinic atlas in the Bundesrat	DP

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	11:13am	MT
Fresenius : Investor Relations Company Presentation	Apr. 12	PU
Fresenius : MAbxience and Teva announce strategic global license agreement for biosimilar oncology treatment	Apr. 04	PU
Fresenius : Management Board buys own shares	Apr. 04	PU
DD: Fresenius SE & Co. KGaA: Robert Möller, buy	Apr. 04	EQ
DD: Fresenius SE & Co. KGaA: Sara Hennicken, buy	Apr. 04	EQ
DD: Fresenius SE & Co. KGaA: Pierluigi Antonelli, buy	Apr. 04	EQ
DD: Fresenius SE & Co. KGaA: Michael Sen, buy	Apr. 04	EQ
AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution	Apr. 02	EQ
Cannabis law and clinic atlas in the Bundesrat	Mar. 22	DP
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	Mar. 21	MT
Criticism of hospital reform: 'Redistribution from the bottom to the top'	Mar. 20	DP
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT
Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar	Mar. 18	MT
Fresenius Settles With Johnson & Johnson to Market Stelara Alternative	Mar. 18	DJ
Fresenius : Kabi and Formycon reach settlement agreement for ustekinumab biosimilar candidate	Mar. 18	PU
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading	Mar. 15	MT
Fresenius : Financial Statements 2022 (HGB)	Mar. 14	PU
Fresenius : Participations in affiliated and associated companies 2023	Mar. 14	PU
Fresenius : Annual Report 2023 (IFRS)	Mar. 14	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

FRESENIUS : A good ending does not allow for extreme optimism in 2024

February 22, 2024 at 07:42 am EST